<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26696">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01842815</url>
  </required_header>
  <id_info>
    <org_study_id>CYN12-PICO-SK</org_study_id>
    <nct_id>NCT01842815</nct_id>
  </id_info>
  <brief_title>Evaluation of the 755nm Alexandrite for Unwanted Tattoos</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect further data on the safety and efficacy of removing
      unwanted non cosmetic tattoos (including recalcitrant) using a 755nm Alexandrite laser.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>TATTOO CLEARANCE</measure>
    <time_frame>3 Months post last treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clearance will be measured using a photographic scale.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Unwanted, Non Cosmetic, Tattoos</condition>
  <arm_group>
    <arm_group_label>755nm Alexandrite Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>755nm Alexandrite Laser for Treatment of unwanted, non cosmetic tattoos</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>755 nm alexandrite laser</intervention_name>
    <description>755 nm alexandrite laser for the treatment of unwante, non cosmetic, tattoos.</description>
    <arm_group_label>755nm Alexandrite Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Is a healthy male or female between 18 and 85 years old.

          2. Has unwanted non-cosmetic tattoo(s) and wishes to undergo laser treatments to remove
             them.

          3. Is willing to consent to participate in the study.

          4. Is willing to comply with all requirements of the study including being photographed,
             following post treatment care and attending all treatment and follow up visits.

        Exclusion Criteria:

          1. Is hypersensitive to light exposure.

          2. Has active localized or systemic infection.

          3. Is taking medication(s) for which sunlight is a contraindication.

          4. Has a history of squamous cell carcinoma or melanoma.

          5. Has a history of keloid scarring.

          6. Has used oral isotretinoin (AccutaneÂ®) within 12 months of initial treatment or plans
             on using during the course of the study. Note: Skin must regain its normal degree of
             moisture prior to treatment.

          7. Has a history of immunosuppression/immune deficiency disorders (including HIV
             infection or AIDS) or use of immunosuppressive medications.

          8. Is female and pregnant, has been pregnant within the last 3 months, is currently
             breast feeding or planning a pregnancy during the study period.

          9. Is allergic to lidocaine, tetracaine or Xylocaine with epinephrine.

         10. Has any other reason determined by the physician to be ineligible to participate in
             the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laser &amp; Skin Surgery Center of Northern California</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 3, 2014</lastchanged_date>
  <firstreceived_date>April 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
